{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:02:37Z","timestamp":1760853757828},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.jviromet.2013.09.008","type":"journal-article","created":{"date-parts":[[2013,10,4]],"date-time":"2013-10-04T03:55:35Z","timestamp":1380858935000},"page":"67-71","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Development of a high-throughput human cytomegalovirus quantitative PCR cell-based assay"],"prefix":"10.1016","volume":"195","author":[{"given":"Sonia","family":"Tremblay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Dansereau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Balsitis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Franti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louie","family":"Lamorte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2013.09.008_bib0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0166-3542(01)00208-X","article-title":"Broad-spectrum antiviral activity of PNU-183792, a 4-oxo-dihydroquinoline, against human and animal herpesviruses","volume":"54","author":"Brideau","year":"2002","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jviromet.2013.09.008_bib0010","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/87979","article-title":"A quantitative assay for HIV DNA integration in vivo","volume":"7","author":"Butler","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.jviromet.2013.09.008_bib0015","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1386-6532(00)00165-7","article-title":"Progress in understanding cytomegalovirus drug resistance","volume":"21","author":"Emery","year":"2001","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jviromet.2013.09.008_bib0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.antiviral.2004.10.003","article-title":"Inhibition of herpesvirus replication by a series of 4-oxo-dihydroquinolines with viral polymerase activity","volume":"65","author":"Hartline","year":"2005","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jviromet.2013.09.008_bib0025","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1517\/14656566.2012.658775","article-title":"Antiviral treatment of cytomegalovirus infection: an update","volume":"13","author":"H\u00e4rter","year":"2012","journal-title":"Exp. Opin. Pharmacother."},{"key":"10.1016\/j.jviromet.2013.09.008_bib0030","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1128\/JVI.78.3.1289-1300.2004","article-title":"Specific inhibition of human cytomegalovirus glycoprotein B-mediated fusion by a novel thiourea small molecule","volume":"78","author":"Jones","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2013.09.008_bib0035","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1600-6143.2011.03530.x","article-title":"First report of successful treatment of multidrug-resistant cytomegalovirus disease with the novel anti-CMV compound AIC246","volume":"11","author":"Kaul","year":"2011","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jviromet.2013.09.008_bib0040","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/jmv.10193","article-title":"Inhibition of clinical isolates of human cytomegalovirus and varicella zoster virus by PNU-183792, a 4-oxo-dihydroquinoline","volume":"68","author":"Knechtel","year":"2002","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jviromet.2013.09.008_bib0045","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1128\/AAC.44.3.688-692.2000","article-title":"A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates","volume":"44","author":"Landry","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jviromet.2013.09.008_bib0050","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1086\/519941","article-title":"Incidence and clinical features of ganciclovir-resistant cytomegalovirus disease in heart transplant recipients","volume":"45","author":"Li","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jviromet.2013.09.008_bib0055","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1128\/AAC.01596-09","article-title":"In vitro and in vivo activities of the novel anticytomegalovirus compound AIC246","volume":"54","author":"Lischka","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jviromet.2013.09.008_bib0060","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1086\/512368","article-title":"Change over time in incidence of ganciclovir resistance in patients with cytomegalovirus retinitis","volume":"44","author":"Martin","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jviromet.2013.09.008_bib0065","doi-asserted-by":"crossref","first-page":"14976","DOI":"10.1073\/pnas.2136652100","article-title":"Coding potential of laboratory and clinical strains of human cytomegalovirus","volume":"100","author":"Murphy","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.jviromet.2013.09.008_bib0070","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/1471-2334-10-147","article-title":"Surveillance of active human cytomegalovirus infection in hematopoietic stem cell transplantation (HLA sibling identical donor): search for optimal cutoff value by real-time PCR","volume":"1","author":"Peres","year":"2010","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.jviromet.2013.09.008_bib0075","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.antiviral.2008.09.009","article-title":"Rapid determination of antiviral drug susceptibility of human cytomegalovirus by real-time PCR","volume":"81","author":"Schnepf","year":"2009","journal-title":"Antiviral. Res."},{"key":"10.1016\/j.jviromet.2013.09.008_bib0080","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1001\/archopht.116.2.178","article-title":"Clinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistance","volume":"116","author":"Smith","year":"1998","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jviromet.2013.09.008_bib0085","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.bmcl.2010.01.094","article-title":"The design and development of 2-aryl-2-hydroxy ethylamine substituted 1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamides as inhibitors of human cytomegalovirus polymerase","volume":"20","author":"Tanis","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jviromet.2013.09.008_bib0090","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093413003959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093413003959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T07:30:36Z","timestamp":1539329436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093413003959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":18,"alternative-id":["S0166093413003959"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2013.09.008","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a high-throughput human cytomegalovirus quantitative PCR cell-based assay","name":"articletitle","label":"Article Title"},{"value":"Journal of Virological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviromet.2013.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}